永顺生物
(920729)
| 流通市值：5.95亿 | | | 总市值：21.16亿 |
| 流通股本：7682.50万 | | | 总股本：2.73亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 43,556,072.4 | 19,281,429.19 | 17,323,119.52 | 12,935,651.82 |
| 交易性金融资产 | 51,063,829.96 | 50,067,094.09 | 29,822,082.19 | 22,785,636.26 |
| 应收票据及应收账款 | 68,477,893.51 | 66,424,173.37 | 82,053,407.67 | 83,221,409.9 |
| 其中：应收票据 | 1,965,939.77 | 886,852.06 | 6,491,080.5 | 6,189,740.53 |
| 应收账款 | 66,511,953.74 | 65,537,321.31 | 75,562,327.17 | 77,031,669.37 |
| 应收款项融资 | 393,872.8 | 272,740 | 1,571,837.2 | 4,267,560 |
| 预付款项 | 429,724.24 | 550,527.5 | 602,666.33 | 109,510.99 |
| 其他应收款合计 | 2,296,652.24 | 2,559,192.38 | 2,495,851.25 | 2,311,804.55 |
| 存货 | 38,313,026.63 | 35,017,952.09 | 32,007,701.09 | 28,252,743.03 |
| 一年内到期的非流动资产 | 64,719,795.12 | 118,981,878.45 | - | - |
| 其他流动资产 | - | - | 446,277,703.78 | 426,435,529.19 |
| 流动资产合计 | 269,250,866.9 | 293,154,987.07 | 612,154,369.03 | 580,319,845.74 |
| 非流动资产: | | | | |
| 其他债权投资 | 361,503,777.77 | 329,598,125 | - | - |
| 其他非流动金融资产 | 150,000 | 150,000 | 150,000 | 150,000 |
| 固定资产 | 137,337,825.67 | 144,333,881.76 | 151,087,804.58 | 157,941,648.75 |
| 在建工程 | - | - | 340,816.84 | 340,816.84 |
| 使用权资产 | 308,222.41 | 462,087.02 | 599,525 | 736,962.98 |
| 无形资产 | 13,551,408.62 | 14,458,084.02 | 15,326,203.35 | 12,617,844.35 |
| 长期待摊费用 | 3,183,216.84 | 3,388,081.32 | 2,211,587.48 | 1,411,226.97 |
| 递延所得税资产 | 474,160.13 | - | - | 201,538.22 |
| 其他非流动资产 | 8,529,700 | 8,310,270 | 9,185,246.01 | 9,665,265.31 |
| 非流动资产合计 | 525,038,311.44 | 500,700,529.12 | 178,901,183.26 | 183,065,303.42 |
| 资产总计 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 | 763,385,149.16 |
| 流动负债: | | | | |
| 短期借款 | 496,265.84 | - | - | - |
| 应付票据及应付账款 | 63,014,206.5 | 66,461,606.01 | 73,148,846.52 | 66,777,200.3 |
| 应付账款 | 63,014,206.5 | 66,461,606.01 | 73,148,846.52 | 66,777,200.3 |
| 预收款项 | - | - | 19,800 | - |
| 合同负债 | 13,798,124.64 | 17,859,829.96 | 21,903,560.04 | 15,118,415.28 |
| 应付职工薪酬 | 3,838,481.51 | 6,605,711.28 | 4,852,064.93 | 3,255,602.62 |
| 应交税费 | 3,255,067.88 | 1,567,767.32 | 1,637,308.36 | 1,089,919.32 |
| 其他应付款合计 | 19,412,594.02 | 17,783,095.39 | 17,877,615.14 | 18,088,941.87 |
| 一年内到期的非流动负债 | 349,888.11 | 502,486.08 | 611,689.51 | 613,305.49 |
| 其他流动负债 | 1,713,506.32 | 535,794.94 | 574,671.9 | 367,302.46 |
| 流动负债合计 | 105,878,134.82 | 111,316,290.98 | 120,625,556.4 | 105,310,687.34 |
| 非流动负债: | | | | |
| 租赁负债 | 9,929.16 | 9,911.6 | 50,761.44 | 195,457.96 |
| 递延收益 | 6,966,212.35 | 6,717,801.72 | 7,609,102.46 | 8,252,433.23 |
| 递延所得税负债 | - | 148,136.29 | 23,985.68 | - |
| 非流动负债合计 | 6,976,141.51 | 6,875,849.61 | 7,683,849.58 | 8,447,891.19 |
| 负债合计 | 112,854,276.33 | 118,192,140.59 | 128,309,405.98 | 113,758,578.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 273,350,000 | 273,350,000 | 273,350,000 | 273,350,000 |
| 资本公积 | 219,487,771.76 | 218,799,344.16 | 216,856,269.22 | 214,299,618.62 |
| 减:库存股 | 15,234,500 | 15,234,500 | 15,234,500 | 15,234,500 |
| 盈余公积 | 73,064,391.34 | 73,064,391.34 | 68,938,593.58 | 68,938,593.58 |
| 未分配利润 | 130,767,238.91 | 125,684,140.1 | 118,835,783.51 | 108,272,858.43 |
| 归属于母公司股东权益合计 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 | 649,626,570.63 |
| 股东权益合计 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 | 649,626,570.63 |
| 负债和股东权益合计 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 | 763,385,149.16 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-28 | 2025-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |